Jardine Matheson

Jardine Matheson is a diversified Asian-based group with a broad portfolio of market-leading businesses.

See below for the Latest Jardine Matheson News, Analysis, Profit Results, Share Price Information, and Commentary.

Jardine Matheson to buy I-MED Radiology for $3.1b

Jardine Matheson to buy I-MED Radiology for $3.1b

The deal gives it full control of I-MED clinics across Australia and New Zealand.

Daily Markets Briefing: STI up 0.38%; Top stock is Genting Sing

Genting Singapore Limited is the top stock but fell 0.73%.

Daily Markets Briefing: STI up 1.38%; Top stock is Singtel

Singapore Telecommunications Limited is the top stock with a 2.58% increase.

Jardine Matheson swings to $1.41b net profit in 2025

This reverses a previous net loss of $594m (US$468m).

Jardine Matheson buys remaining Mandarin Oriental shares after OCB sale

Mandarin Oriental shareholders will receive $0.77 per share dividend.

Mandarin Oriental shareholders OK Jardine Matheson deal

Jardine Matheson will acquire 11.96% of Mandarin's total issued shares.

Wilmar CEO Kuok Khoon Hong is oldest corporate leader in SBR list

In 1991, Kuok helped build Wilmar International that is now regarded as a palm oil giant.

What does a top Singapore CEO look like today?

Most lead the same firms they joined decades ago, rising from finance, engineering, or operations into the top job.

Jardine Matheson Holdings appoints ex-PAG Lincoln Pan as new CEO

John Witt has announced his resignation by the end of November.

Jardine Matheson reports $623m net loss for FY2024

This was due to lower contributions from Zhongsheng and Hongkong Land.

Jardine Matheson’s underlying profit sinks 33% in H1 2024

The decline was mainly due to weaker contributions from Hongkong Land.

Jardine Matheson projects modest profit decline in 2024 

The company cited market conditions for the profit decline.

Jardine Matheson’s net profit soars to US$686m in FY23

Full-year dividend also increased, jumping 5% YoY.